Efficacy of brief motivational interviewing on smoking cessation at tuberculosis clinics in Tshwane, South Africa: A randomized controlled trial

Addiction

Volumn 109, Issue 11, 2014, Pages 1942-1952

  Louwagie, Goedele M C ^a   Okuyemi, Kolawole S ^b   Ayo Yusuf, Olalekan A ^a,c  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF LIMPOPO   (South Africa)

Author keywords

HIV; Lay health care worker; Randomized controlled trial; Tobacco; Tobacco cessation; Tuberculosis

Indexed keywords

ADULT; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH CARE FACILITY; HUMAN; MALE; MIDDLE AGED; MOTIVATIONAL INTERVIEWING; MULTICENTER STUDY; MULTILEVEL ANALYSIS; PREVENTION AND CONTROL; PROCEDURES; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; SMOKING; SMOKING CESSATION; SOUTH AFRICA; TREATMENT OUTCOME; TUBERCULOSIS;

ADULT; FEMALE; FOLLOW-UP STUDIES; HEALTH FACILITIES; HUMANS; MALE; MIDDLE AGED; MOTIVATIONAL INTERVIEWING; MULTILEVEL ANALYSIS; SMOKING; SMOKING CESSATION; SOUTH AFRICA; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 84908021088     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.12671     Document Type: Article

References (63)

1. World Health Organization. Global Tuberculosis Report 2012. Geneva: WHO; 2012. WHO/HTM/TB/2012.6. Available at: http://apps.who.int/iris/bitstream/10665/75938/1/9789241564502_eng.pdf (accessed 10 July 2014) (Archived at http://www.webcitation.org/6QxWwwVPs on 10 July 2014).
2. Bates M. N., Khalakdina A., Pai M., Chang L., Lessa F., Smith K. R. Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Arch Intern Med 2007; 167: 335-342.
3. Lin H. H., Ezzati M., Murray M. Tobacco smoke, indoor air pollution and tuberculosis: a systematic review and meta-analysis. PLoS Med 2007; 4: e20. doi: 10.1371/journal.pmed.0040020.
4. Slama K., Chiang C. Y., Enarson D. A., Hassmiller K., Fanning A., Gupta P. etal. Tobacco and tuberculosis: a qualitative systematic review and meta-analysis. Int J Tuberc Lung Dis 2007; 11: 1049-1061.
5. Maciel E. L., Brioschi A. P., Peres R. L., Guidoni L. M., Ribeiro F. K., Hadad D. J. etal. Smoking and 2-month culture conversion during anti-tuberculosis treatment. Int J Tuberc Lung Dis 2013; 17: 225-228.
6. Tachfouti N., Nejjari C., Benjelloun M. C., Berraho M., Elfakir S., El Rhazi K. etal. Association between smoking status, other factors and tuberculosis treatment failure in Morocco. Int J Tuberc Lung Dis 2011; 15: 838-843.
7. Thomas A., Gopi P. G., Santha T., Chandrasekaran V., Subramani R., Selvakumar N. etal. Predictors of relapse among pulmonary tuberculosis patients treated in a DOTS programme in South India. Int J Tuberc Lung Dis 2005; 9: 556-561.
8. Jee S. H., Golub J. E., Jo J., Park I. S., Ohrr H., Samet J. M. Smoking and risk of tuberculosis incidence, mortality, and recurrence in South Korean men and women. Am J Epidemiol 2009; 170: 1478-1485.
9. d' Arc Lyra Batista J., de Fatima Pessoa Militao de Albuquerque M., de Alencar Ximenes R. A., Rodrigues L. C. Smoking increases the risk of relapse after successful tuberculosis treatment. Int J Epidemiol 2008; 37: 841-851.
10. Ruddy M., Balabanova Y., Graham C., Fedorin I., Malomanova N., Elisarova E. etal. Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia. Thorax 2005; 60: 130-135.
11. Holt P. G. Immune and inflammatory function in cigarette smokers. Thorax 1987; 42: 241-249.
12. Dye J. A., Adler K. B. Effects of cigarette smoke on epithelial cells of the respiratory tract. Thorax 1994; 49: 825-834.
13. Arcavi L., Benowitz N. L. Cigarette smoking and infection. Arch Intern Med 2004; 164: 2206-2216.
14. Feldman C., Anderson R. Cigarette smoking and mechanisms of susceptibility to infections of the respiratory tract and other organ systems. J Infect 2013; 67: 169-184.
15. Chang K. C., Leung C. C., Tam C. M. Risk factors for defaulting from anti-tuberculosis treatment under directly observed treatment in Hong Kong. Int J Tuberc Lung Dis 2004; 8: 1492-1498.
16. Naidoo P., Peltzer K., Louw J., Matseke G., Mchunu G., Tutshana B. Predictors of tuberculosis (TB) and antiretroviral (ARV) medication non-adherence in public primary care patients in South Africa: a cross sectional study. BMC Public Health 2013; 13: 396. doi: 10.1186/1471-2458-13-396.
17. Miguez-Burbano M. J., Ashkin D., Rodriguez A., Duncan R., Pitchenik A., Quintero N. etal. Increased risk of Pneumocystis carinii and community-acquired pneumonia with tobacco use in HIV disease. Int J Infect Dis 2005; 9: 208-217.
18. Crothers K., Griffith T. A., McGinnis K. A., Rodriguez-Barradas M. C., Leaf D. A., Weissman S. etal. The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans. J Gen Intern Med 2005; 20: 1142-1145.
19. Marshall M. M., McCormack M. C., Kirk G. D. Effect of cigarette smoking on HIV acquisition, progression, and mortality. AIDS Educ Prev 2009; 21: 28-39.
20. van Zyl Smit R. N., Pai M., Yew W. W., Leung C. C., Zumla A., Bateman E. D. etal. Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD. Eur Respir J 2010; 35: 27-33.
21. Helleberg M., Afzal S., Kronborg G., Larsen C. S., Pedersen G., Pedersen C. etal. Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study. Clin Infect Dis 2013; 56: 727-734.
22. Shin S. S., Xiao D., Cao M., Wang C., Li Q., Chai W. X. etal. Patient and doctor perspectives on incorporating smoking cessation into tuberculosis care in Beijing, China. Int J Tuberc Lung Dis 2012; 16: 126-131.
23. El Sony A., Slama K., Salieh M., Elhaj H., Adam K., Hassan A. etal. Feasibility of brief tobacco cessation advice for tuberculosis patients: a study from Sudan. Int J Tuberc Lung Dis 2007; 11: 150-155.
24. Pradeepkumar A. S., Thankappan K. R., Nichter M. Smoking among tuberculosis patients in Kerala, India: proactive cessation efforts are urgently needed. Int J Tuberc Lung Dis 2008; 12: 1139-1145.
25. Sereno A. B., Soares E. C., Lapa E Silva J. R., Napoles A. M., Bialous S. A., Costa E Silva V. L. etal. Feasibility study of a smoking cessation intervention in Directly Observed Therapy Short-Course tuberculosis treatment clinics in Rio de Janeiro, Brazil. Rev Panam Salud Publica 2012; 32: 451-456.
26. Ng N., Padmawati R. S., Prabandari Y. S., Nichter M. Smoking behavior among former tuberculosis patients in Indonesia: intervention is needed. Int J Tuberc Lung Dis 2008; 12: 567-572.
27. Siddiqi K., Khan A., Ahmad M., Dogar O., Kanaan M., Newell J. N. etal. Action to stop smoking in suspected tuberculosis (ASSIST) in Pakistan: a cluster randomized, controlled trial. Ann Intern Med 2013; 158: 667-675.
28. Siddiqi K., Khan A., Ahmad M., Rehman S. U. An intervention to stop smoking among patients suspected of TB-evaluation of an integrated approach. BMC Public Health 2010; 10: 160. doi: 10.1186/1471-2458-10-160.
29. National Council Against Smoking. Make a Fresh Start. Your personal guide to stop smoking. Available at: http://againstsmoking.co.za/images/makeafreshstart.pdf (accessed 2 May 2014) (Archived at http://www.webcitation.org/6PGbVFrtQ on 2 May 2014).
30. Rollnick S., Butler C. C., Stott N. Helping smokers make decisions: the enhancement of brief intervention for general medical practice. Patient Educ Couns 1997; 31: 191-203.
31. Rollnick S., Miller W. R. What is motivational interviewing? Behav Cogn Psychother 1995; 23: 325-334.
32. Rubak S., Sandbaek A., Lauritzen T., Christensen B. Motivational interviewing: a systematic review and meta-analysis. Br J Gen Pract 2005; 55: 305-312.
33. Lai D. T., Cahill K., Qin Y., Tang J. L. Motivational interviewing for smoking cessation. Cochrane Database Syst Rev 2010; 1: CD006936. doi: 10.1002/14651858.CD006936.pub2.
34. Heckman C. J., Egleston B. L., Hofmann M. T. Efficacy of motivational interviewing for smoking cessation: a systematic review and meta-analysis. Tob Control 2010; 19: 410-416.
35. Fiore M. C., Jaén C. R., Baker T. B., Bailey W. C., Benowitz N. L., Curry S. J. etal. Chapter 3. Clinical interventions for tobacco use and dependence. In: Clinical Practice Guideline. Treating Tobacco Use and Dependence: 2008 Update. Rockville, MD: US Department of Health and Human Services. Public Health Service; 2008, pp. 37-60.
36. Miller W. R., Yahne C. E., Moyers T. B., Martinez J., Pirritano M. A randomized trial of methods to help clinicians learn motivational interviewing. J Consult Clin Psychol 2004; 72: 1050-1062.
37. Mitcheson L., Bhavsar K., McCambridge J. Randomized trial of training and supervision in motivational interviewing with adolescent drug treatment practitioners. J Subst Abuse Treat 2009; 37: 73-78.
38. West R., Hajek P., Stead L., Stapleton J. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction 2005; 100: 299-303.
39. Hughes J. R., Keely J. P., Niaura R. S., Ossip-Klein D. J., Richmond R. L., Swan G. E. Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res 2003; 5: 13-25.
40. Jarvis M. J., Tunstall-Pedoe H., Feyerabend C., Vesey C., Saloojee Y. Comparison of tests used to distinguish smokers from nonsmokers. Am J Public Health 1987; 77: 1435-1438.
41. Waage H., Silsand T., Urdal P., Langard S. Discrimination of smoking status by thiocyanate and cotinine in serum, and carbon monoxide in expired air. Int J Epidemiol 1992; 21: 488-493.
42. Global Adult Tobacco Survey Collaborative Group. Global Adult Tobacco Survey (GATS): Core Questionnaire with Optional Questions, Version 2.0. Atlanta, GA: Centers for Disease Control and Prevention; 2010. Available at: http://www.who.int/tobacco/surveillance/en_tfi_gats_corequestionnairewithoptionalquestions_v2_FINAL_03Nov2010.pdf (accessed 10 July 2014) (Archived at http://www.webcitation.org/6QxXUokeg on 10 July 2014).
43. de Leon J., Diaz F. J., Becona E., Gurpegui M., Jurado D., Gonzalez-Pinto A. Exploring brief measures of nicotine dependence for epidemiological surveys. Addict Behav 2003; 28: 1481-1486.
44. Mahoney J., Drinka T. J., Abler R., Gunter-Hunt G., Matthews C., Gravenstein S. etal. Screening for depression: single question versus GDS. J Am Geriatr Soc 1994; 42: 1006-1008.
45. Cohen S., Kamarck T., Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983; 24: 385-396.
46. Sherbourne C. D., Stewart A. L. The MOS social support survey. Soc Sci Med 1991; 32: 705-714.
47. Ewing J. A. Detecting alcoholism. The CAGE questionnaire. JAMA 1984; 252: 1905-1907.
48. Velicer W. F., Diclemente C. C., Rossi J. S., Prochaska J. O. Relapse situations and self-efficacy: an integrative model. Addict Behav 1990; 15: 271-283.
49. Prochaska J. O., DiClemente C. C. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol 1983; 51: 390-395.
50. Stata Corporation. Stata Statistical Software: Release 12. College Station, TX: StatCorp; 2011.
51. Louwagie G. M., Ayo-Yusuf O. A. Tobacco use patterns in tuberculosis patients with high rates of human immunodeficiency virus co-infection in South Africa. BMC Public Health 2013; 13: 1031. doi: 10.1186/1471-2458-13-1031.
52. Dewing S., Mathews C., Schaay N., Cloete A., Louw J., Simbayi L. 'It's important to take your medication everyday okay?' An evaluation of counselling by lay counsellors for ARV adherence support in the Western Cape, South Africa. AIDS Behav 2013; 17: 203-212.
53. Peltzer K., Naidoo P., Louw J., Matseke G., Zuma K., Mchunu G. etal. Screening and brief interventions for hazardous and harmful alcohol use among patients with active tuberculosis attending primary public care clinics in South Africa: results from a cluster randomized controlled trial. BMC Public Health 2013; 13: 699.
54. Fairall L. R., Bachmann M. O., Louwagie G. M., van Vuuren C., Chikobvu P., Steyn D. etal. Effectiveness of antiretroviral treatment in a South African program: a cohort study. Arch Intern Med 2008; 168: 86-93.
55. Dewing S., Mathews C., Cloete A., Schaay N., Shah M., Simbayi L. etal. From research to practice: lay adherence counsellors' fidelity to an evidence-based intervention for promoting adherence to antiretroviral treatment in the Western cape, South Africa. AIDS Behav 2013; 17: 2935-2945.
56. Landaw S. A. The effects of cigarette smoking on total body burden and excretion rates of carbon monoxide. J Occup Med 1973; 15: 231-235.
57. Ahluwalia J. S., Okuyemi K., Nollen N., Choi W. S., Kaur H., Pulvers K. etal. The effects of nicotine gum and counseling among African American light smokers: a 2×2 factorial design. Addiction 2006; 101: 883-891.
58. Faseru B., Nollen N. L., Mayo M. S., Krebill R., Choi W. S., Benowitz N. L. etal. Predictors of cessation in African American light smokers enrolled in a bupropion clinical trial. Addict Behav 2013; 38: 1796-1803.
59. Lando H. A. Lay facilitators as effective smoking cessation counselors. Addict Behav 1987; 12: 69-72.
60. Andrews J. O., Felton G., Ellen Wewers M., Waller J., Tingen M. The effect of a multi-component smoking cessation intervention in African American women residing in public housing. Res Nurs Health 2007; 30: 45-60.
61. Hood N. E., Ferketich A. K., Paskett E. D., Wewers M. E. Treatment adherence in a lay health adviser intervention to treat tobacco dependence. Health Educ Res 2013; 28: 72-82.
62. Louwagie G., Girdler-Brown B., Odendaal R., Rossouw T., Johnson S., Van der Walt M. Missed opportunities for accessing HIV care among Tshwane tuberculosis patients under different models of care. Int J Tuberc Lung Dis 2012; 16: 1052-1058.
63. Department of Health Republic of South Africa. Government Gazette Vol. 554, No.34523. National Health Act (61/2003): Policy on National Health Insurance. Pretoria: Government Printing Works; 2011.